The TRIM3 expression log fold change (responders vs. non-responders to FOLFOX) −1.36 in all stages of cancer samples suggesting that the smaller amount of TRIM3 leads to more growth and proliferation which can make the cancer more susceptible to FOLFOX (Zhao, 2016). This evidence concerns the gene TRIM3 and cancer.